Cointime

Download App
iOS & Android

Merrimack Pharmaceuticals

company
Exit Type
IPO
Exit Date
Mar 29, 2012

Exit parties in this round

Partner Fund Round Return Amount Return Multiplier
Hercules Capital Post-IPO Debt Detail
National Institutes of Health Grant Detail
WT Investment Advisors Fund Series D Detail
Wharton Capital Series C Detail